Regional distribution of serotonin transporter protein in postmortem human brain - Is the cerebellum a SERT-free brain region?

被引:155
作者
Kish, SJ [1 ]
Furukawa, Y
Chang, LJ
Tong, JC
Ginovart, N
Wilson, A
Houle, S
Meyer, JH
机构
[1] Ctr Addict & Mental Hlth, Human Neurochem Pathol Lab, Toronto, ON M5T 1R8, Canada
[2] Ctr Addict & Mental Hlth, PET Ctr, Toronto, ON M5T 1R8, Canada
关键词
serotonin transporter; serotonin; positron emission tomography; brain; ecstasy; neurotoxicity;
D O I
10.1016/j.nucmedbio.2004.10.001
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Introduction: The primary approach in assessing the status of brain serotonin neurons in human conditions such as major depression and exposure to the illicit drug ecstasy has been the use of neuroimaging procedures involving radiotracers that bind to the serotonin transporter (SERT). However, there has been no consistency in the selection of a "SERT-free" reference region for the estimation of free and nonspecific binding, as occipital cortex, cerebellum and white matter have all been employed. Objective and Methods: To identify areas of human brain that might have very low SERT levels, we measured, by a serniquantitative Western blotting procedure, SERT protein immunoreactivity throughout the postmortem brain of seven normal adult subjects. Results: Serotonin transporter could be quantitated in all examined brain areas. However, the SERT concentration in cerebellar cortex and white matter were only at trace values, being approximately 20% of average cerebral cortex and 5% of average striatum values. Conclusion: Although none of the examined brain areas are completely free of SERT, human cerebellar cortex has low SERT binding as compared to other examined brain regions, with the exception of white matter. Since the cerebellar cortical SERT binding is not zero, this region will not be a suitable reference region for SERT radioligands with very low free and nonspecific binding. For SERT radioligands with reasonably high free and nonspecific binding, the cerebellar cortex should be a useful reference region, provided other necessary radioligand assumptions are met. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:123 / 128
页数:6
相关论文
共 32 条
  • [1] HIGH-AFFINITY [H-3] PAROXETINE BINDING TO SEROTONIN UPTAKE SITES IN HUMAN-BRAIN TISSUE
    BACKSTROM, I
    BERGSTROM, M
    MARCUSSON, J
    [J]. BRAIN RESEARCH, 1989, 486 (02) : 261 - 268
  • [2] VERTEILUNG DES 5-HYDROXYTRYPTAMINS (SEROTONIN) IM GEHIRN DES MENSCHEN UND SEIN VERHALTEN BEI PATIENTEN MIT PARKINSON-SYNDROM
    BERNHEIMER, H
    BIRKMAYER, W
    HORNYKIEWICZ, O
    [J]. KLINISCHE WOCHENSCHRIFT, 1961, 39 (20): : 1056 - +
  • [3] Buchert R, 2003, J NUCL MED, V44, P375
  • [4] Evaluation of serotonergic transporters using PET and [11C](+)McN-5652:: Assessment of methods
    Buck, A
    Gucker, PM
    Schönbächler, RD
    Arigoni, M
    Kneifel, S
    Vollenweider, FX
    Ametamey, SM
    Burger, C
    [J]. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2000, 20 (02) : 253 - 262
  • [5] SEROTONINERGIC TERMINAL TRANSPORTERS ARE DIFFERENTIALLY AFFECTED IN PARKINSONS-DISEASE AND PROGRESSIVE SUPRANUCLEAR PALSY - AN AUTORADIOGRAPHIC STUDY WITH [H-3] CITALOPRAM
    CHINAGLIA, G
    LANDWEHRMEYER, B
    PROBST, A
    PALACIOS, JM
    [J]. NEUROSCIENCE, 1993, 54 (03) : 691 - 699
  • [6] AUTORADIOGRAPHY OF ANTIDEPRESSANT BINDING-SITES IN THE HUMAN-BRAIN - LOCALIZATION USING [H-3]IMIPRAMINE AND [H-3] PAROXETINE
    CORTES, R
    SORIANO, E
    PAZOS, A
    PROBST, A
    PALACIOS, JM
    [J]. NEUROSCIENCE, 1988, 27 (02) : 473 - 496
  • [7] Positron emission tomography quantification of [11C]-DASB binding to the human serotonin transporter:: Modeling strategies
    Ginovart, N
    Wilson, AA
    Meyer, JH
    Hussey, D
    Houle, S
    [J]. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2001, 21 (11) : 1342 - 1353
  • [8] Increased protein levels of serotonin transporter in frontal cortex of patients with Down syndrome
    Gulesserian, T
    Engidawork, E
    Cairns, N
    Lubec, G
    [J]. NEUROSCIENCE LETTERS, 2000, 296 (01) : 53 - 57
  • [9] Comparison of [H-3]paroxetine and [H-3]cyanoimipramine for quantitative measurement of serotonin transporter sites in human brain
    Gurevich, EV
    Joyce, JN
    [J]. NEUROPSYCHOPHARMACOLOGY, 1996, 14 (05) : 309 - 323
  • [10] Marked disparity between age-related changes in dopamine and other presynaptic dopaminergic markers in human striatum
    Haycock, JW
    Becker, L
    Ang, L
    Furukawa, Y
    Hornykiewicz, O
    Kish, SJ
    [J]. JOURNAL OF NEUROCHEMISTRY, 2003, 87 (03) : 574 - 585